About Amorchem
AmorChem l.p., our fourth focused fund, was launched in 2011 to increase the commercial potential of the quality academic research carried out in Quebec. AmorChem is focused on investing in promising life science projects originating from Québec-based universities and research centres. AmorChem’s innovative business model involves financing research-stage projects to enable them to reach pre-clinical proof-of-concept in a semi-virtual mode. AmorChem will generate returns through a two-pronged exit strategy:
Investment Details
Investment Range
Not specified
Investment Stage
Various stages
Industry Focus
Venture Capital, Education, VR/AR
Investor Type
Venture Capital
Investment Focus
Focus Areas
Investment Stages